BIRC5 and cancer: For instance, herpes simplex virus cannot always achieve cancer-specific viral replication using cancer-specific promoters, including TERT and survivin promoters.20,21 Thus, the highly controllable viral replication and strictly target cell-specific cytotoxicity are major advantages of m-CRA relative to several other types of oncolytic virus.